CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

92.36 0.22 −0.24%
Market cap
$118.4B
P/E
24.1×
Fwd P/E
15.4×
Dividend yield
3.60%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100

CVS Health Corporation (CVS) EBITDA

Alert me on EBITDA

CVS Health Corporation's EBITDA for fiscal 2025 was $15.0B, up 14.3% from $13.1B in fiscal 2024. Over the twelve months to 30 June 2026 it was $18.5B. Over the past ten years it has ranged from $11.6B (fiscal 2015) to $18.4B (fiscal 2020); the current reading is higher than 64% of that period. CVS Health Corporation ranks 2nd of 12 Healthcare Plans companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $15.0B 14.32%
FY2024 $13.1B (27.59%)
FY2023 $18.1B 48.70%
FY2022 $12.2B (33.19%)
FY2021 $18.2B (0.68%)
FY2020 $18.4B 12.19%
FY2019 $16.4B 26.92%
FY2018 $12.9B 5.66%
FY2017 $12.2B (5.16%)
FY2016 $12.9B 11.19%

Quarterly newest first

Period EBITDA Change
Jun 2026 $5.8B 0.59%
Mar 2026 $5.8B 77.82%
Dec 2025 $3.3B (10.76%)
Sep 2025 $3.7B 2.82%
42 more quarters

Against its own ten years

Low $11.6B High $18.4B
Ten-year median $13.1B
Current reading's percentile 64

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on CVS